B
BICYCLE THERAPEUTICS LTD
NASDAQ: BCYC (Bicycle Therapeutics plc)
Kemas kini terakhir: 2 minit lalu14.68
-0.32 (-2.13%)
Penutupan Terdahulu | 15.00 |
Buka | 15.00 |
Jumlah Dagangan | 343,475 |
Purata Dagangan (3B) | 592,989 |
Modal Pasaran | 1,013,595,328 |
Harga / Jualan (P/S) | 20.96 |
Harga / Buku (P/B) | 1.25 |
Julat 52 Minggu | |
Tarikh Pendapatan | 18 Feb 2025 - 24 Feb 2025 |
Margin Operasi (TTM) | -2,385.87% |
EPS Cair (TTM) | -3.28 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -50.00% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 1.33% |
Nisbah Semasa (MRQ) | 17.13 |
Aliran Tunai Operasi (OCF TTM) | -202.62 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -141.18 M |
Pulangan Atas Aset (ROA TTM) | -15.02% |
Pulangan Atas Ekuiti (ROE TTM) | -26.67% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Bercampur | Bercampur |
Biotechnology (Global) | Bercampur | Bercampur | |
Stok | Bicycle Therapeutics plc | Menurun | Menurun |
AISkor Stockmoo
2.1
Konsensus Penganalisis | 3.0 |
Aktiviti Orang Dalam | 2.5 |
Volatiliti Harga | 5.0 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | -2.5 |
Purata | 2.10 |
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. |
|
Sektor | Healthcare |
Industri | Biotechnology |
% Dimiliki oleh Orang Dalam | 1.30% |
% Dimiliki oleh Institusi | 92.37% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Baker Bros. Advisors Lp | 30 Sep 2024 | 9,399,960 |
Deep Track Capital, Lp | 30 Sep 2024 | 3,548,001 |
Fcpm Iii Services B.V. | 30 Sep 2024 | 2,339,961 |
Ra Capital Management, L.P. | 30 Sep 2024 | 2,253,000 |
Armistice Capital, Llc | 30 Sep 2024 | 1,956,000 |
Westfield Capital Management Co Lp | 30 Sep 2024 | 1,850,945 |
Price T Rowe Associates Inc /Md/ | 30 Sep 2024 | 1,722,040 |
Tybourne Capital Management (Hk) Ltd | 30 Sep 2024 | 1,394,535 |
Morgan Stanley | 30 Sep 2024 | 1,349,894 |
Candriam S.C.A. | 30 Sep 2024 | 1,050,598 |
Polar Capital Holdings Plc | 30 Sep 2024 | 1,002,780 |
First Light Asset Management, Llc | 30 Sep 2024 | 967,006 |
Camber Capital Management Lp | 30 Sep 2024 | 915,000 |
Ecor1 Capital, Llc | 30 Sep 2024 | 910,000 |
Point72 Asset Management, L.P. | 30 Sep 2024 | 899,799 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 38.00 (Needham, 158.86%) | Beli |
Median | 29.50 (100.95%) | |
Rendah | 17.00 (B. Riley Securities, 15.80%) | Pegang |
Purata | 29.00 (97.55%) | |
Jumlah | 4 Beli, 2 Pegang | |
Harga Purata @ Panggilan | 19.23 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
JMP Securities | 18 Dec 2024 | 26.00 (77.11%) | Beli | 15.32 |
HC Wainwright & Co. | 16 Dec 2024 | 33.00 (124.80%) | Beli | 15.12 |
01 Nov 2024 | 55.00 (274.66%) | Beli | 22.71 | |
B. Riley Securities | 13 Dec 2024 | 17.00 (15.80%) | Pegang | 13.81 |
Stephens & Co. | 08 Nov 2024 | 25.00 (70.30%) | Pegang | 24.96 |
RBC Capital | 01 Nov 2024 | 35.00 (138.42%) | Beli | 22.71 |
Needham | 31 Oct 2024 | 38.00 (158.86%) | Beli | 23.45 |
24 Oct 2024 | 38.00 (158.86%) | Beli | 24.77 |
Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
---|---|---|---|---|
BAKER BROS. ADVISORS LP | 14.47 | - | 1,485,397 | 21,168,333 |
Jumlah Keseluruhan Kuantiti Bersih | 1,485,397 | |||
Jumlah Keseluruhan Nilai Bersih ($) | 21,168,333 | |||
Purata Pembelian Keseluruhan ($) | 14.47 | |||
Purata Jualan Keseluruhan ($) | - |
Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | Pengarah | 16 Dec 2024 | Beli (+) | 500,000 | 15.12 | 7,560,000 |
BAKER BROS. ADVISORS LP | Pengarah | 13 Dec 2024 | Beli (+) | 985,397 | 13.81 | 13,608,333 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2024 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |